Shailesh Shrikhande

Shailesh V. Shrikhande

MS (Mumbai), MD (Heidelberg), FRCS (Hon, London), FASA (Hon, USA), FACS (Hon, USA), FRCS (Hon, Edin)

Shailesh V. Shrikhande is the Chief Executive of Tata Cancer Care Foundation (TCCF), Director of GI and HPB Cancer Surgery at Gleneagles Hospital, Parel, Mumbai, and a Consultant Surgeon at Breach Candy Hospital and Shrikhande Clinic, Mumbai, India. He is also the Officer on Special Duty at Tata Memorial Centre. Previously, he was Head of GI and HPB Surgery (2010-2025) and Deputy Director of Tata Memorial Hospital (2018-2025), Mumbai.

He was ranked first in the Master of Surgery examinations of Mumbai University in 1997 and later received specialist training in Pancreatic Research and Pancreatic Surgery at the University of Bern, Switzerland and the University of Heidelberg, Germany. He was the first Asian to receive the Kenneth Warren Fellowship of the International Hepato-Pancreato-Biliary Association (IHPBA) in 2005. He earned his Doctor of Medicine (magna cum laude) by the University of Heidelberg for his original clinical and basic research on chronic pancreatitis and pancreatic cancer in 2006. He has delivered over 600 lectures and orations all over the world. Apart from having published over 370 clinical and basic science research papers in leading peer-reviewed journals (including a series of 1200 Whipple Resections), Professor Shrikhande has also given 65 live operative masterclass demonstrations on pancreatic, gastric, gall bladder and colorectal cancer across India and abroad. He has contributed over 75 book chapters and is the Chief Editor of the books “Surgery of Pancreatic tumours” (2007) and “Pancreatic Cancer: Current Understanding” (2011), ‘Modern Gastrointestinal Oncology (2015) and Pancreas (2023). His h-index (perhaps the best indicator of true scientific merit) stands at 67; the highest amongst his peers across India and amongst the best in the world. He has been an invited Visiting Professor to 12 prestigious Universities in the USA, Europe and Japan. He is Adjunct Professor in Surgical Oncology in KMC, Manipal and in KLE University Hospital, Belgaum.  

He was the Chairman of the Indian Council Medical Research (ICMR) committee for developing guidelines for the management of Pancreatic and Gastric Cancer in India. He is the associate editor of Langenbecks Archives of Surgery and serves on the editorial boards of leading international journals of GI and HPB surgery. He is the Past President of the Indian Chapter of IHPBA. He is the Immediate Past President of the APHPBA (the youngest ever) and the Secretary-General Elect of the IHPBA (The first Indian ever). In recognition of his work on pancreatic cancer and digestive cancer surgery in India, he was awarded an Honorary Fellowship from the Royal College of Surgeons of England in 2014 (FRCS – Ad Eundem) and the Honorary Fellowship (ad hominem) of the Royal College of Surgeons of Edinburgh in March 2025. In 2021, he became only the second Indian in the 144-year history of the American Surgical Association (ASA) to be conferred the Honorary Fellowship of ASA for “unusually noteworthy contributions to surgery of long-lasting value and worthy of the highest International Recognition”. He is the only Indian invited to serve as a board member of the International Study Group of Pancreatic Surgery (ISGPS) since 2023. Recently, he was conferred Honorary Fellowship of American College of Surgeons (FACS) in San Francisco at the Annual ACS Congress in October 2024. He is thus the only Indian Surgeon to be conferred by honorary fellowships of the four leading surgical societies in the world. Stanford University published a list of world’s best contributing researchers in the PLOS One journal in November 2021, 2022, 2023 and even in 2024. Professor Shrikhande is ranked amongst the top 2% (amongst >55,000 researchers) worldwide.

In 2021, the Honourable Governor of Maharashtra, His Excellency Shri Bhagat Singh Koshyari, honoured him with “Excellence in Cancer Care” award for his world recognized work on Digestive and Pancreatic Cancer Surgery and his dedication towards building a futuristic cancer centre to serve the needs of the nation for the next 50 years.

In his previous administrative capacity as a Deputy Director and now as Officer on Special Duty at Tata Memorial, he is currently spearheading the Tata Memorial Centre’s expansion plan which shall comprise of a 550-bed state of the art hospital (Platinum Jubilee Block) and even a Dharamshala designed exclusively for poor patients in Mumbai. Thanks to his relentless efforts and leadership, the hospital has already constructed and commissioned a 15 floor Doctors and Nurses Hostel. Furthermore, he secured 100 flats in 2022 from Maharashtra Housing and Area Development Authority (MHADA) to mitigate the suffering of exclusively poor patients and their relatives who seek treatment at Tata Memorial Centre from remote corners of India.

Prof. Shrikhande also provides technical advisory support to charitable institutions for establishing cancer centers, including the Dharmaveer Anand Dighe Cancer Hospital in Thane (in collaboration with the Thane Municipal Corporation and the JITO Trust), Goa Medical College, and Guruji Rugnalay in Nashik.

In his current role of Chief Executive of TCCF, he spearheads the development of cancer care across India in keeping with the objectives of affordable, high quality cancer care that is available and accessible in far flung corners of India.